Literature DB >> 11734547

Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex.

A Matilla1, C Gorbea, D D Einum, J Townsend, A Michalik, C van Broeckhoven, C C Jensen, K J Murphy, L J Ptácek, Y H Fu.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder characterized by ataxia and selective neuronal cell loss caused by the expansion of a translated CAG repeat encoding a polyglutamine tract in ataxin-7, the SCA7 gene product. To gain insight into ataxin-7 function and to decipher the molecular mechanisms of neurodegeneration in SCA7, a two-hybrid assay was performed to identify ataxin-7 interacting proteins. Herein, we show that ataxin-7 interacts with the ATPase subunit S4 of the proteasomal 19S regulatory complex. The ataxin-7/S4 association is modulated by the length of the polyglutamine tract whereby S4 shows a stronger association with the wild-type allele of ataxin-7. We demonstrate that endogenous ataxin-7 localizes to discrete nuclear foci that also contain additional components of the proteasomal complex. Immunohistochemical analyses suggest alterations either of the distribution or the levels of S4 immunoreactivity in neurons that degenerate in SCA7 brains. Immunoblot analyses demonstrate reduced levels of S4 in SCA7 cerebella without evident alterations in the levels of other proteasome subunits. These results suggest a role for S4 and ubiquitin-mediated proteasomal proteolysis in the molecular pathogenesis of SCA7.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734547     DOI: 10.1093/hmg/10.24.2821

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  beta-Endorphin expression in the mouse retina.

Authors:  Shannon K Gallagher; Paul Witkovsky; Michel J Roux; Malcolm J Low; Veronica Otero-Corchon; Shane T Hentges; Jozsef Vigh
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 2.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

3.  A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patients.

Authors:  Claudia Wahl; Sabine Kautzmann; Guido Krebiehl; Karsten Strauss; Dirk Woitalla; Thomas Müller; Peter Bauer; Olaf Riess; Rejko Krüger
Journal:  J Neural Transm (Vienna)       Date:  2008-04-30       Impact factor: 3.575

4.  Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.

Authors:  Shona Mookerjee; Theodora Papanikolaou; Stephan J Guyenet; Vanitha Sampath; Amy Lin; Cathy Vitelli; Francesco DeGiacomo; Bryce L Sopher; Sylvia F Chen; Albert R La Spada; Lisa M Ellerby
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 5.  Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.

Authors:  Yasuyo Suzuki; Ikuru Yazawa
Journal:  Int J Clin Exp Pathol       Date:  2011-04-25

Review 6.  Proteasome Biology: Chemistry and Bioengineering Insights.

Authors:  Lucia Račková; Erika Csekes
Journal:  Polymers (Basel)       Date:  2020-12-04       Impact factor: 4.329

Review 7.  The spinocerebellar ataxias: order emerges from chaos.

Authors:  Russell L Margolis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

8.  Pathogenic polyglutamine expansion length correlates with polarity of the flanking sequences.

Authors:  Meewhi Kim
Journal:  Mol Neurodegener       Date:  2014-11-06       Impact factor: 14.195

Review 9.  The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias.

Authors:  Janet E Davies; Sovan Sarkar; David C Rubinsztein
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

Review 10.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.